Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Cancer Chemotherapy and Pharmacology
|
October 25, 2014
Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections
Karen D Wright, John C Panetta, Arzu Onar-Thomas, et al.
Journal of Neuro-Oncology
|
June 3, 2026
Neoadjuvant chemotherapy for pineal region tumors
Christopher Troy, David G Laird, Cameron Brimley, et al.
Oncotarget
|
June 12, 2020
Phase I study of vemurafenib in children with recurrent or progressive BRAF<sup>V600E</sup> mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002)
Theodore Nicolaides, Kellie J Nazemi, John Crawford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 28, 2019
Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children's Oncology Group (ACNS1221)
Lucie Lafay-Cousin, Eric Bouffet, Douglas Strother, et al.
British Journal of Clinical Pharmacology
|
October 29, 2019
Pharmacokinetic basis for dosing high-dose methotrexate in infants and young children with malignant brain tumours
John C Panetta, Jessica K Roberts, Jie Huang, et al.
NPJ Precision Oncology
|
October 2, 2024
Comparison of DNA methylation based classification models for precision diagnostics of central nervous system tumors
Quynh T Tran, Alex Breuer, Tong Lin, et al.
Pediatric Blood & Cancer
|
February 8, 2014
Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma
Johnnie K Bass, Jie Huang, Arzu Onar-Thomas, et al.
Pediatric Blood & Cancer
|
January 6, 2021
A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042)
David Van Mater, Sridharan Gururangan, Oren Becher, et al.
Science Translational Medicine
|
January 21, 2021
Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma
Raelene Endersby, Jacqueline Whitehouse, Allison Pribnow, et al.
Nature
|
December 15, 2010
Subtypes of medulloblastoma have distinct developmental origins
Paul Gibson, Yiai Tong, Giles Robinson, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Cancer Chemotherapy and Pharmacology
|
October 25, 2014
Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections
Karen D Wright, John C Panetta, Arzu Onar-Thomas, et al.
Journal of Neuro-Oncology
|
June 3, 2026
Neoadjuvant chemotherapy for pineal region tumors
Christopher Troy, David G Laird, Cameron Brimley, et al.
Oncotarget
|
June 12, 2020
Phase I study of vemurafenib in children with recurrent or progressive BRAF<sup>V600E</sup> mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002)
Theodore Nicolaides, Kellie J Nazemi, John Crawford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 28, 2019
Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children's Oncology Group (ACNS1221)
Lucie Lafay-Cousin, Eric Bouffet, Douglas Strother, et al.
British Journal of Clinical Pharmacology
|
October 29, 2019
Pharmacokinetic basis for dosing high-dose methotrexate in infants and young children with malignant brain tumours
John C Panetta, Jessica K Roberts, Jie Huang, et al.
NPJ Precision Oncology
|
October 2, 2024
Comparison of DNA methylation based classification models for precision diagnostics of central nervous system tumors
Quynh T Tran, Alex Breuer, Tong Lin, et al.
Pediatric Blood & Cancer
|
February 8, 2014
Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma
Johnnie K Bass, Jie Huang, Arzu Onar-Thomas, et al.
Pediatric Blood & Cancer
|
January 6, 2021
A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042)
David Van Mater, Sridharan Gururangan, Oren Becher, et al.
Science Translational Medicine
|
January 21, 2021
Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma
Raelene Endersby, Jacqueline Whitehouse, Allison Pribnow, et al.
Nature
|
December 15, 2010
Subtypes of medulloblastoma have distinct developmental origins
Paul Gibson, Yiai Tong, Giles Robinson, et al.
Page
of 3